Comparative Study of Professional vs Mass Market Topical Products for Treatment of Facial Photodamage

January 2016 | Volume 15 | Issue 1 | Original Article | 37 | Copyright © 2016

Hilary Reich MD,a,b Irmina Wallander BA,a Lacie Schulte MS BA,a Molly Goodier BS,a and Brian Zelickson MDa

aZel Skin & Laser Specialist, Edina, MN
bUniversity of Minnesota Department of Dermatology, MN

Abstract

SUMMARY BACKGROUND: Many over the counter topical products claim to reverse the signs of cutaneous photo-damage. To date, the two most studied ingredients for improving the texture, tone, and pigmentation of the skin are topical retinoids and hydroquinone.1
OBJECTIVE: This split face study compares a mass market skincare regimen with a prescription skin care regimen for improvement in photo damaged skin.
METHODS: Twenty-seven subjects with moderate photo damaged facial skin were enrolled.   Each subject was consented and assigned with the mass market anti-aging system (Treatment A) to one side of the face and the prescription anti-aging system (Treatment B or Treatment C) to the other side of the face. Treatment B contained 13 subjects whom did not use 0.025% Retinol cream. Treatment C contained 14 subjects who used a 0.025% Retinol Cream. Subjects had 4 visits over 12 weeks for digital photography and surveys. Photographs were evaluated by blinded physicians.
RESULTS: Physician objective analysis showed all three systems to have a statistically significant clinical improvement in photoaged skin seen in as little as 4 weeks of use. Participant’s surveys rated the mass market system higher than both of the professional systems for visible skin changes, ease of use, and likelihood to recommend to a friend. Twelve of twenty-seven subjects preferred the mass market system for overall improvement while twelve thought each system gave the same improvement.
CONCLUSION: This study demonstrates that a mass marketed skin care system can give similar clinical improvements in photo-aged skin as a professionally dispensed prescription system and the majority of participants preferred the mass-marketed system.

J Drugs Dermatol. 2016;15(1):37-44.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

INTRODUCTION

Many topical products claim to reverse the signs of cutaneous photodamage, namely dyspigmentation and rhytid development. To date, the two most studied ingredients for improving the texture, tone, and pigmentation of the skin are topical retinoids and hydroquinone.

All-trans-retinoic acid (tretinoin), a naturally occurring metabolite of retinol, a form of Vitamin A, was the first retinoid to be synthesized, and has been used in topical skin care applications for acne reduction and treatment of photoaging since 1969.2 Several strengths and formulations are commercially available in the US. Clinical studies have demonstrated efficacy of tretinoin, a prescription-strength retinoid, as a topical agent for the treatment of photodamaged skin,3 but the potential for side effects such as dryness, scaling, erythema, itching, burning, and photosensitivity4 may limit patient tolerance and duration of use.

Hydroquinone (1, 4 dihydroxybenzene) has long been used to treat cutaneous hyperpigmentation including melasma, solar and senile lentigines, ephilides, post-inflammatory hyperpigmentation, and other forms of dyschromia. Applied topically, hydroquinone acts as a tyrosine inhibitor to halt a critical step in melanogenesis.5 Despite its effectiveness, hydroquinone has several potential side effects including an irritant, allergic contact dermatitis, and exogenous ochronosis.6 A variety of neoplasms have been reported in rodent studies where the animals received large systemic doses of the medication, but relevance to topical therapy in humans has not been determined.7 Because of these concerns, hydroquinone has been removed from Japanese and European markets. In the US, 2% formulations are available over the counter, while 3% solution and 4% cream or gel require a prescription.

While tretinoin and hydroquinone are among the most commonly prescribed topical agents for treatment of cutaneous photoaging, several barriers to their use exist. Prescription strength hydroquinone and all tretinoin formulations require a physician assessment to obtain a prescription. Annual monitoring of retinoic acid and quarterly monitoring of 4% hydroquinone is the generally accepted protocol for safety and efficacy.

Other retinoids and hydroquinone formulations are available in over the counter cosmetic preparations. These products may be less irritating than their prescription-strength rival,8 however, there are few, if any, clinical studies comparing over the counter versus prescription strength products. The objective of this

↑ back to top


Related Articles